The Southern United States saw a concentrated burst of dental M&A activity in February, with 10 acquisitions completed in a single month across Texas, Virginia, Tennessee, North Carolina, and Maryland. The buyers represent a cross-section of the DSO landscape: Beacon Oral Specialists continued its specialty-focused rollup, Salt Dental Partners expanded its general dentistry footprint, Straine Dental Management added practices in the Mid-Atlantic, and PDS Health — one of the largest DSOs nationally — made moves that signal continued appetite for Southern markets. The geographic clustering is not coincidental — these states combine population growth, favorable regulatory environments, and fragmented practice ownership, making them prime targets for consolidation.

The South has emerged as the most active theater for dental M&A over the past two years, and the data supports the thesis. Texas, Florida, and the Carolinas consistently rank among the top states for deal volume in Praxis AI's deal tracker, driven by net domestic migration that has added millions of residents — and dental patients — since 2020. Virginia and Maryland offer proximity to the affluent D.C. metro corridor, while Tennessee's business-friendly tax structure and growing Nashville healthcare ecosystem attract both strategic buyers and PE-backed platforms. The 10-deals-in-one-month pace, if sustained, would represent a meaningful acceleration from the already elevated baseline of 2025, when Southern states accounted for roughly 35% of all tracked dental transactions nationally.

For practice owners in these markets, the signal is clear: buyer competition is intensifying, which generally supports valuations. But the mix of acquirers matters. Beacon's focus on oral surgery reflects the premium that specialty practices command — often 8–12x EBITDA versus 5–7x for general dentistry. Salt and Straine's general practice acquisitions suggest that mid-market DSOs are filling in geographic gaps to achieve density, a strategy that unlocks referral networks and shared overhead efficiencies. PDS Health's participation indicates that even the largest platforms see room to grow in a region where independent practice ownership still exceeds 60% in most markets. For DSOs already operating in the South, the competitive landscape is getting more crowded, and the cost of acquisition is likely trending upward.

Watch for whether this pace holds through Q2 2026 — a sustained 10-plus deals per month in Southern states would represent a step-change in consolidation velocity. Monitor PDS Health's broader acquisition strategy, as the company's recent leadership changes and operational restructuring may signal a more aggressive M&A posture. Track whether specialty-focused platforms like Beacon begin competing directly with general DSOs for multi-specialty group practices. And pay attention to valuation multiples in Texas and the Carolinas, where buyer density is highest — if multiples compress, it could indicate that the market is approaching saturation in key metros.